Literature DB >> 12403074

Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats.

Mari Jiko1, Ikuko Yano, Hiroko Wakasugi, Hideyuki Saito, Ken-ichi Inui.   

Abstract

PURPOSE: The purpose of this study was to clarify the mechanism of pharmacokinetic interaction between cyclosporin A and probucol in clinical cases.
METHODS: The whole blood concentration of cyclosporin A was measured after oral administration of cyclosporin A with or without probucol in rats. Cyclosporin A was administered as three types of solutions: the contents of the conventional formulation (Sandimmun capsule) diluted with corn oil and the contents of the new microemulsion preconcentrate formulation (Neoral capsule) diluted with saline or corn oil. The solubility of cyclosporin A and another lipophilic agent tacrolimus in water with or without probucol was also measured.
RESULTS: The area under the blood concentration-time curve (AUC) after the administration of Sandimmun (corn oil) and Neoral (corn oil) was significantly decreased to 26% and 41% of the control by coadministration of probucol. However in the case of Neoral (saline), it was unchanged. The terminal elimination rate constant was not affected by probucol in any type of cyclosporin A solution. The solubility of cyclosporin A or tacrolimus in water dropped to 49% or 16% of the respective control in the presence of probucol.
CONCLUSION: The interaction between cyclosporin A and probucol is caused by the decreased absorption of cyclosporin A partly based on the lowered solubility in the presence of probucol.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403074     DOI: 10.1023/a:1020363111398

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

Review 2.  Significance of cyclosporine pharmacokinetics.

Authors:  J Grevel
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

3.  Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation.

Authors:  E A Mueller; J M Kovarik; J B van Bree; J Grevel; P W Lücker; K Kutz
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

Review 4.  The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

Authors:  D W Holt; E A Mueller; J M Kovarik; J B van Bree; K Kutz
Journal:  Transplant Proc       Date:  1994-10       Impact factor: 1.066

5.  Pharmacokinetics of probucol in male rats.

Authors:  J F Heeg; M F Hiser; D K Satonin; J Q Rose
Journal:  J Pharm Sci       Date:  1984-12       Impact factor: 3.534

6.  Effect of bile on cyclosporin absorption in liver transplant patients.

Authors:  M U Mehta; R Venkataramanan; G J Burckart; R J Ptachcinski; B Delamos; S Stachak; D H Van Thiel; S Iwatsuki; T E Starzl
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

7.  Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats.

Authors:  N Balandraud-Pieri; P E Queneau; F X Caroli-Bosc; P Bertault-Pérès; A M Montet; A Durand; J C Montet
Journal:  Drug Metab Dispos       Date:  1997-08       Impact factor: 3.922

8.  Decrease in oral bioavailability of cyclosporin A by coadministration of probucol in rats.

Authors:  K Sugimoto; K Sakamoto; A Fujimura
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

9.  Human P-glycoprotein transports cyclosporin A and FK506.

Authors:  T Saeki; K Ueda; Y Tanigawara; R Hori; T Komano
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

10.  The absorption site of cyclosporin in the human gastrointestinal tract.

Authors:  J Drewe; C Beglinger; T Kissel
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.